About: Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 May 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en mayu de 2019 (ast) im Mai 2019 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 20 May 2019 (en) наукова стаття, опублікована 20 травня 2019 (uk)
publication date	wds:Q92156802-7754D17C-87F5-4AF7-B1D7-2BF154D58211
publication date	2019-05-20 00:00:00Z (xsd:dateTime)
cites work	wds:Q92156802-00B267C3-9E77-4D7A-9E41-EA3A179F47FE wds:Q92156802-148C3B05-7CB3-4CD7-AE0E-F3B36ED083D3 wds:Q92156802-170A3BD1-2FD3-471E-BB63-0321BCF0589C wds:Q92156802-297B6679-6365-4007-8414-B9A6950A55D2 wds:Q92156802-33AE961F-47FC-4207-9619-21C50206BA4A wds:Q92156802-370BFF25-7BA5-4432-8CFB-30E3FE48F6CA wds:Q92156802-40AD7C22-3866-4DC3-A962-E40D89864181 wds:Q92156802-484FE96F-02A9-4817-82F1-6CBE69D16170 wds:Q92156802-4CB057D9-EDB8-45AB-825E-9F320E57C9E9 wds:Q92156802-58941B9D-868A-442A-BB37-0CFF78AD5EA5 wds:Q92156802-837002D9-08A0-4682-8066-8A87AA794073 wds:Q92156802-8978B11D-BC3E-4E92-91F1-C55EDEEEA98C wds:Q92156802-8CF78EBA-701F-4495-A288-1F4E3BD8B152 wds:Q92156802-905A16D9-8996-4BFB-A22F-4ACB7146FC88 wds:Q92156802-923C61C6-D5EE-4B64-8532-D5F9FAD6AAEF wds:Q92156802-B7960CCD-1AD5-4773-AC6B-CDDFC2FBC8BD wds:Q92156802-BDBCE6DF-9AA7-4B06-88C3-844016FFB613 wds:Q92156802-CE6B0143-E7BF-4734-98A1-82AD2E20AB09 wds:Q92156802-D10AB84C-41FF-4DD6-9BE6-616F090A695F wds:Q92156802-DCDC4299-16FC-421C-B1E8-B77BD751CE1A wds:Q92156802-E988CB67-381A-4DD8-91A2-925EBA242C5F wds:Q92156802-FBF6BD51-E5C8-449B-B5C3-DA2D6241A8D1 wds:Q92156802-FC18ABA5-FDE8-4273-8FFF-5A8DB75C1147 wds:Q92156802-FD3E296B-85AC-46A6-9E0A-9F3A9092DC42
cites work	The global programme to eliminate lymphatic filariasis: health impact after 8 years Albendazole: a review of anthelmintic efficacy and safety in humans Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo The global programme to eliminate lymphatic filariasis Ivermectin 20 years on: maturation of a wonder drug Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus Sample size computations for PK/PD population models Experimental infection of humans with filariae. Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics Diagnostic Tools for Onchocerciasis Elimination Programs. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects LC-MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study. Changes in cytokine, filarial antigen, and DNA levels associated with adverse events following treatment of lymphatic filariasis Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis Global programme to eliminate lymphatic filariasis: progress report, 2016 Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies
author name string	wds:Q92156802-0C6B9C45-22A5-41C2-8789-E33922810DC5 wds:Q92156802-108B5495-2520-4ABF-BB7F-7E84970C3123 wds:Q92156802-496E47A4-EE33-4925-9374-C1EAE1225E63 wds:Q92156802-63D4018F-E896-4AEB-A8C6-0270F7736B9D wds:Q92156802-9F99D53E-7D78-4502-964F-91474C47B786 wds:Q92156802-AD7102C4-6738-45FC-A049-52DA1CAD6912 wds:Q92156802-C51B0138-4CFB-44B7-AAA5-699C28B91C26 wds:Q92156802-F6FA8F90-322E-4E30-809C-C45736CF78A3
author name string	Gary J Weil Daryl J Murry Benjamin G Koudou Yashpal S Chhonker Louis K Penali Constant Edi Aboulaye Méité Catherine M Bjerum
rdfs:label	Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (en) Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (nl)
skos:prefLabel	Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (en) Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (nl)
name	Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (en) Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (nl)
author	wds:Q92156802-204CAC01-00F7-4F58-B730-D70F3D343262 wds:Q92156802-B3869CDD-1CFB-4546-844D-688C282CB1AD
author	Christopher L King Allassane F Ouattara
title	wds:Q92156802-16AC24BC-EC6A-439B-9038-90356388D944
title	Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire (en)
page(s)	wds:Q92156802-E8352277-1E9F-4BE2-B024-E5731F9088E3
page(s)	e0007325
instance of	wds:Q92156802-A0B03C81-7D66-4215-A13E-58A69353F175
instance of	scholarly article
main subject	wds:Q92156802-310FDDAD-A5B8-4789-82E0-3F4DC9D8D075 wds:Q92156802-C2EB5548-E6DC-4B92-B93C-097DEC44295C wds:Q92156802-CA8848A4-F9AC-4F51-A0FA-2CF56C5B18D9 wds:Q92156802-D2D819CC-9FD5-4EF2-A367-962C68CAF3E1
main subject	diethylcarbamazine Ivory Coast ivermectin Wuchereria bancrofti
PubMed ID	wds:Q92156802-1B303A0E-3A20-4FA2-A7AA-7EF2C869C787
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31107869
PubMed ID	31107869
published in	wds:Q92156802-DBB73CE0-D67D-491F-8F08-0085A7E7B02E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software